Cipla to acquire 11.71% stake in Wellthy Therapeutics

Drug major Cipla said it has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics. Goldencross Pharma, a wholly-owned subsidiary of Cipla, has inked an agreement to acquire the minority stake in the Mumbai-based firm for a cash consideration of Rs 10.5 crore.